Antigenic sites of coxsackie A9 virus inducing neutralizing monoclonal antibodies protective in mice

Virology

Volumn 312, Issue 1, 2003, Pages 74-83

  Buttinelli, Gabriele ^a   Donati, Valentina ^a   Ruggeri, Franco M ^a   Joki Korpela, Paivi ^b   Hyypia, Timo ^b   Fiore, Lucia ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Coxsackievirus A9; Epitope; IgG; Immunity; Monoclonal antibody; Neutralization; Protection

Indexed keywords

AMINO ACID; EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PURIFICATION; ANTIGENICITY; ARTICLE; COXSACKIE VIRUS A; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; MOUSE; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS NEUTRALIZATION;

COXSACKIEVIRUS; MURINAE;

EID: 0042167556     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00182-X     Document Type: Article

References (40)

1. Baum H., Brusic V., Choudhuri K., Cunningham P., Vergani D., Peakman M. MHC molecular mimicry in diabetes. Nat. Med. 1:1995;338.
2. Bernstein F.C., Koetzle T.F., Williams G.J., Meyer E.E. Jr., Brice M.D., Rodgers J.R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank a computer-based archival file for macromolecular structures . J. Mol. Biol. 112:1977;535-542.
3. Blondel B., Crainic R., Fichot O., Dufraisse G., Candrea A., Diamond D., Girard M., Horaud F. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. J. Virol. 57:1986;81-90.
4. Chang K.H., Auvinen P., Hyypia T., Stanway G. The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification. J. Gen. Virol. 70:1989;3269-3280.
5. Chatterjee N.K. Antibodies to glutamic acid decarboxylase and P2-CV peptides in sera from coxsackievirus B4-infected mice and IDDM patients. Diabetes. 43:1994;1260-1266.
6. D'Alessio D.J. A case-control study of group B coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am. J. Epidemiol. 135:1992;1331-1338.
7. Diamond D.C., Jameson B.A., Bonin J., Kohara M., Abe S., Itoh H., Komatsu T., Arita M., Kuge S., Nomoto A., et al. Antigenic variation and resistance to neutralization in poliovirus type 1. Science. 229:1985;1090-1093.
8. Filman D.J., Syed R., Chow M., Macadam A.J., Minor P.D., Hogle J.M. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8:1989;1567-1579.
9. Fiore L., Ridolfi B., Genovese D., Buttinelli G., Lucioli S., Lahm A., Ruggeri F.M. Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies. J. Virol. 71:1997;6905-6912.
10. Fox G., Parry N.R., Barnett P.V., McGinn B., Rowlands D.J., Brown F. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J. Gen. Virol. 70:1989;625-637.
11. Greenberg H.B., Valdesuso J., van Wyke K., Midthun K., Walsh M., McAuliffe V., Wyatt R.G., Kalica A.R., Flores J., Hoshino Y. Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J. Virol. 47:1983;267-275.
12. Grist N.R., Bell E.J., Assaad F. Enteroviruses in human disease. Prog. Med. Virol. 24:1978;114-157.
13. Harvala H., Kalimo H., Dahllund L., Santti J., Hughes P., Hyppia T., Stanway G. Mapping of tissue tropism determinants in coxsackievirus genomes. J. Gen. Virol. 83:2002;1697-1706.
14. Hendry E., Hatanaka H., Fry E., Smyth M., Tate J., Stanway G., Santti J., Maaronen M., Hyypia T., Stuart D.I. The crystal structure of coxsackievirus A9 new insights into the uncoating mechanisms of enteroviruses . Struct. Fold Des. 7:1999;1527-1538.
15. Hewat E.A., Blaas D. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2. EMBO J. 15:1996;1515-1523.
16. Hewat E.A., Verdaguer N., Fita I., Blakemore W., Brookes S., King A., Newman J., Domingo E., Mateu M.G., Stuart D.I. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and mouth disease virus positioning of a highly mobile antigenic loop . EMBO J. 16:1997;1492-1500.
17. Hogle J.M., Chow M., Filman D.J. Three-dimensional structure of poliovirus at 2.9 A resolution. Science. 229:1985;1358-1365.
18. Hovi T., Stenvik M., Rosenlew M. Relative abundance of enterovirus serotypes in sewage differs from that in patients clinical and epidemiological implications . Epidemiol. Infect. 116:1996;91-97.
19. Hughes P.J., Horsnell C., Hyypia T., Stanway G. The coxsackievirus A9 RGD motif is not essential for virus viability. J. Virol. 69:1995;8035-8040.
20. Hyoty H., Hiltunen M., Knip M., Laakkonen M., Vahasalo P., Karjalainen J., Koskela P., Roivainen M., Leinikki P., Hovi T., et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes. 44:1995;652-657.
21. Hyypia T., Kallajoki M., Maaronen M., Stanway G., Kandolf R., Auvinen P., Kalimo H. Pathogenic diffrences between coxsackie A and B virus infections in newborn mice. Virus Res. 27:1993;71-78.
22. Joki-Korpela P., Roivainen M., Lankinen H., Poyry T., Hyypia T. Antigenic properties of human parechovirus 1. J. Gen. Virol. 7:2000;1709-1718.
23. Kinnunen E., Hovi T., Stenvik M., Hellstrom O., Porras J., Kleemola M., Kantanen M.L. Localized outbreak of enteroviral meningitis in adults. Acta Neurol. Scand. 75:1987;346-351.
24. Minor P.D. Antigenic structure of picornaviruses. Curr. Top. Microbiol. Immunol. 161:1990;122-154.
25. Minor P.D., Evans D.M., Ferguson M., Schild G.C., Westrop G., Almond J.W. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J. Gen. Virol. 66:1985;1159-1165.
26. Minor P.D., Ferguson M., Evans D.M., Almond J.W., Icenogle J.P. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J. Gen. Virol. 67:1986;1283-1291.
27. Page G.S., Mosser A.G., Hogle J.M., Filman D.J., Rueckert R.R., Chow M. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J. Virol. 62:1988;1781-1794.
28. Pincus S.H., Cole R., Ireland R., McAtee F., Fujisawa R., Portis J. Protective efficacy of nonneutrallizing monoclonal antibodies in acute infection with murine leukemia virus. J. Virol. 69:1995;7152-7158.
29. Pulli T., Lankinen H., Roivainen M., Hyypia T. Antigenic sites of coxsackievirus A9. Virology. 240:1998;202-212.
30. Pulli T., Roivainen M., Hovi T., Hyypia T. Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1. J. Gen. Virol. 79:1998;2249-2253.
31. Roivainen M., Hyypia T., Piirainen L., Kalkkinen N., Stanway G., Hovi T. RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J. Virol. 65:1991;4735-4740.
32. Roivainen M., Knip M., Hyoty H., Kulmala P., Hiltunen M., Vahasalo P., Hovi T., Akerblom H.K. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. J. Med. Virol. 56:1998;74-78.
33. Roivainen M., Piirainen L., Hovi T. Efficient RGD-independent entry process of coxsackievirus A9. Arch. Virol. 141:1996;1909-1919.
34. Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T., Heino J., Hyypia T. Entry of coxsackievirus A9 into host cells specific interactions with alpha v beta 3 integrin, the vitronectin receptor . Virology. 203:1994;357-365.
35. Smith T.J., Olson N.H., Cheng R.H., Chase E.S., Baker T.S. Structure of a human rhinovirus-bivalently bound antibody complex implications for viral neutralization and antibody flexibility . Proc. Natl. Acad. Sci. USA. 90:1993;7015-7018.
36. Thomas A.A., Brioen P., Boeye A. A monoclonal antibody that neutralizes poliovirus by cross-linking virions. J. Virol. 54:1985;7-13.
37. Triantafilou M., Triantafilou K., Wilson K.M., Takada Y., Fernandez N., Stanway G. Involvement of beta2-microglobulin and integrin alphavbeta3 molecules in the coxsackievirus A9 infectious cycle. J. Gen. Virol. 80:1999;2591-2600.
38. Weber B., Rabenau H., Cinatl J., Maass G., Doerr H.W. Quantitative detection of neutralizing antibodies against polioviruses and non-polio enteroviruses (NPEV) using an automated microneutralization assay a seroepidemiologic survey . Zentralbl. Bakteriol. 280:1994;540-549.
39. Wiegers K., Uhlig H., Dernick R. N-AgIB of poliovirus type 1 a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152 . Virology. 170:1989;583-586.
40. Wiegers K.J., Wetz K., Dernick R. Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1. J. Virol. 64:1990;1283-1289.